Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time? : Editorial to: "Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)" by M. Goicoechea et al

Cardiovasc Drugs Ther. 2018 Jun;32(3):241-243. doi: 10.1007/s10557-018-6803-0.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aspirin
  • Cardiovascular Diseases*
  • Disease Progression
  • Humans
  • Primary Prevention
  • Renal Insufficiency, Chronic*

Substances

  • Aspirin